Sort
11,323 grants matching “glioblastoma”
Bone marrow derived neural stem cell therapy for glioma
$412,500John S Yu · Cedars-Sinai Medical Center · R56 · FY2010 · NS
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
$412,459Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Inhibition of the ALK Receptor Kinase
$412,421Anton Wellstein · Georgetown University · R01 · FY2006 · CA
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$412,267Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2024 · CA
Nanotherapeutic treatment of the invasive glioblastoma microenvironment
$412,157Graeme F Woodworth · University Of Maryland Baltimore · R01 · FY2021 · NS
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
$412,116David R Grosshans · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$412,090Richard B Silverman · Northwestern University · R01 · FY2021 · CA
PROJECT 2: NF1-associated Glioblastoma
$412,057Luis F Parada · Indiana University Indianapolis · U54 · FY2023 · CA
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
$411,930Arvind P Pathak · Johns Hopkins University · R01 · FY2023 · CA
Defining Therapeutic Paradigms Based on Molecular Profiling of GBM
$411,930Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$411,884John H Sampson · Duke University · P01 · FY2012 · CA
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$411,688Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2021 · NS
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$411,688Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2023 · NS
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$411,688Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2022 · NS
Underlying vasculature and perivasculature direct fluid flow in and around tumors
$411,583Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R21 · FY2025 · CA
Pharmacological targeting of circadian clock components to treat glioblastoma
$411,549Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2020 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$411,464Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2020 · CA
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$411,170John H Sampson · Duke University · R01 · FY2013 · NS
Biophysical Interrogation of Signals that Drive GBM Invasion
$411,131Adam J Engler · University Of California, San Diego · R01 · FY2021 · NS
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
$411,108Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2019 · CA
Hollow Fiber Catheter for Drug Delivery into the Brain
$410,962Jim Stice · Twin Star Medical · R43 · FY2008 · NS
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$410,877Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$410,877Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$410,675Robert M Prins · University Of California Los Angeles · R01 · FY2020 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$410,675Robert M Prins · University Of California Los Angeles · R01 · FY2019 · CA